COMMUNIQUÉS West-GlobeNewswire

Aquestive Therapeutics to Participate in Citizens Life Sciences Conference
05/05/2025
WARREN, N.J., May 05, 2025 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ: AQST) ("Aquestive" or the "Company"), a pharmaceutical company advancing medicines to bring meaningful improvement to patients' lives [...]
Foghorn Therapeutics to Participate in the Citizens Life Sciences Conference
05/05/2025
CAMBRIDGE, Mass., May 05, 2025 (GLOBE NEWSWIRE) -- Foghorn® Therapeutics Inc. (Nasdaq: FHTX), a clinical-stage biotechnology company pioneering a new class of medicines that treat serious diseases by correcting abnormal [...]
Aptose Provides Clinical Update for the Tuspetinib-based Triple Drug Frontline Therapy in Newly Diagnosed AML Patients from the Phase 1/2 TUSCANY Trial
05/05/2025
Aptose is developing TUS+VEN+AZA as a one-of-a-kind safe and mutation agnostic frontline triple drug therapy for newly diagnosed AML patients First two dose cohorts of TUS+VEN+AZA triplet demonstrate safety, complete [...]
Eupraxia Pharmaceuticals Announces Sustained Positive Treatment Outcomes in Patients with Eosinophilic Esophagitis (EoE) After Nine Months of Receiving EP-104GI
05/05/2025
Eupraxia continues to observe positive treatment outcomes in its ongoing Phase 1b/2a trial, including for the first time clinical responses measured 9 months after dosing with EP-104GI At 9 months active drug continued [...]
Ocular Therapeutix™ Reports First Quarter 2025 Results and Business Highlights
05/05/2025
AXPAXLI™ SOL trials for wet AMD progressing rapidly following recent updates to accelerate and enhance the registrational program Following positive FDA feedback for potential AXPAXLI NPDR registrational trial, Ocular [...]
Vyvamind Under Review: Does Vyvamind Work? Best Adderall Alternative Nootropic Supplement
05/05/2025
Is Vyvamind the best Adderall alternative? Discover how this natural nootropic supplement boosts focus, energy, and mental clarity—backed by science and real reviews. Albany, New York, May 05, 2025 (GLOBE NEWSWIRE) -- [...]
BioNTech Announces First Quarter 2025 Financial Results and Corporate Update
05/05/2025
Continued oncology pipeline advancement with a strategic focus on two priority pan-tumor programs: next-generation immunomodulator BNT327, a bispecific antibody targeting PD-L1 and VEGF-A 1 , and mRNA cancer [...]
Best Male Fertility Supplements: Best Vitamin Supplements For Male Fertility And Male Conception, Fertilaid For Men, Best Sperm Motility Supplement, Best Coq10 For Male Fertility (Semenoll)
05/05/2025
Glasgow, May 05, 2025 (GLOBE NEWSWIRE) -- Boosting Male Fertility Naturally: Diet, Lifestyle & Supplements Having a diet rich in vitamins and minerals—along with a healthy lifestyle that includes proper sleep, [...]
Integra LifeSciences Reports First Quarter 2025 Financial Results
05/05/2025
PRINCETON, N.J., May 05, 2025 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, today reported financial results for the first quarter ending [...]
BioNTech Announces Appointment of Ramón Zapata to Management Board as Chief Financial Officer
05/05/2025
Mainz, Germany, May 5, 2025 (GLOBE NEWSWIRE) – BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) announced today that the Supervisory Board has appointed Ramón Zapata-Gomez to the Management Board as Chief [...]
Best Premature Ejaculation Pills: Treatment, Meaning, How to Treat, What is Premature Ejaculation, Early Ejaculation Problem, How To Avoid Quick Discharge Of Sperm, Causes (Performer 8)
05/05/2025
Glasgow, May 05, 2025 (GLOBE NEWSWIRE) -- 2025: Introduction Performer 8 is a reliable dietary supplement designed to enhance testosterone levels and improve male sexual health. Many men have reported positive outcomes [...]
RetinalGenix Technologies, Inc. Announces Laboratory Lease Agreement with Life Science Incubator MBC BioLabs
05/05/2025
Company to use facility to further development of RetinalGenix’s therapies for neurodegenerative and retinal diseases APOLLO BEACH, Fla., May 05, 2025 (GLOBE NEWSWIRE) -- RetinalGenix Technologies, Inc. (OTCQB:RTGN) (“ [...]
Recursion Reports First Quarter 2025 Financial Results and Provides Business Update
05/05/2025
Pipeline: Delivered on our commitment to a more focused R&D strategy by advancing a streamlined portfolio of 5+ clinical and preclinical programs in oncology and rare disease, while deprioritizing 3 clinical [...]
Aclarion Welcomes Advocate Health as CLARITY Trial Site
05/05/2025
Advocate Health actively participates in research studies and is an innovator in technology, including spine The CLARITY trial is designed to demonstrate Nociscan’s ability to improve surgical outcomes for chronic low [...]
Trading in GN Store Nord shares by board members, executives and associated persons
05/05/2025
GN Store Nord has received notification pursuant to article 19 of regulation (EU) no. 596/2014 of the below transactions related to shares in GN Store Nord made by persons discharging managerial responsibilities in GN [...]
Inventiva secures the €116 million second tranche of its structured financing of up to €348 million
05/05/2025
Financing follows completion of enrollment of Phase 3 NATiV3 study evaluating lanifibranor in MASH and satisfaction of other specified conditions. Daix (France), New York City (New York, United States), May 5, 2025 – [...]
Inventiva obtient la deuxième tranche de 116 millions d'euros de son financement structuré d'un montant maximum de 348 millions d'euros
05/05/2025
Le financement intervient à la suite de la fin du recrutement de l’étude clinique de Phase 3 NATiV3 évaluant lanifibranor chez les patients atteints de MASH et à la suite de l’atteinte d’autres conditions préalables. [...]
Buy Kratom Online – Happy Go Leafy Raises the Bar as The Best Kratom Brand For Premium Products
05/05/2025
Happy Go Leafy is your trusted online source for premium kratom. Shop with confidence, high-quality products that are lab-tested and delivered safely. Miami, Florida, United States, May 05, 2025 (GLOBE NEWSWIRE) -- Ever [...]
Nanobiotix Announces Full Results From Completed Phase 1 Study Evaluating JNJ-1900 (NBTXR3) in Pancreatic Cancer
05/05/2025
Results demonstrated favorable safety, injection feasibility, and encouraging oncologic outcomes in patients (n=22) with locally advanced or borderline resectable pancreatic cancer Median Overall Survival of 23 months [...]

Pages